FGF9 Antikörper (Middle Region)
Kurzübersicht für FGF9 Antikörper (Middle Region) (ABIN3044402)
Target
Alle FGF9 (FGF-9) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 150-164, Middle Region
-
Verwendungszweck
- Anti-Fibroblast growth factor 9 FGF9 Antibody Picoband®
-
Sequenz
- SNLYKHVDTG RRYYV
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-Fibroblast growth factor 9 FGF9 Antibody (ABIN3044402). Tested in IHC, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence in the middle region of human FGF9, identical to the related mouse and rat sequences.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Rat, Mouse
Western blot, 0.1-0.5 μg/mL, Human, Rat, Mouse
1. Mariani, F. V., Ahn, C. P., Martin, G. R.Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning.Nature 453: 401-405, 2008. 2. Mattei, M.-G., Penault-Llorca, F., Coulier, F., Birnbaum, D.The human FGF 9 gene maps to chromosomal region 13q11-q12.Genomics 29: 811-812, 1995. 3. Sun, X., Lewandoski, M., Meyers, E. N., Liu, Y.-H., Maxson, R. E., Jr., Martin, G. R.Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development.Nature Genet. 25: 83-86, 2000. -
Kommentare
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB, supported by ABIN921231 in IHC(P).
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Konservierungsmittel
- Thimerosal (Merthiolate), Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
Haltbarkeit
- 12 months
-
-
- FGF9 (FGF-9) (Fibroblast Growth Factor 9 (FGF-9))
-
Andere Bezeichnung
- FGF9
-
Hintergrund
-
Synonyms: Fibroblast growth factor 9,FGF-9,Glia-activating factor,GAF,Heparin-binding growth factor 9,HBGF-9,FGF9,
Tissue Specificity: Glial cells.
Background: FGF 9, Fibroblast growth factor 9, is a protein that in humans is encoded by the FGF9 gene. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. The FGF 9 gene contains 3 exons. By radioactive chromosomal in situ hybridization, the FGF 9 gene is mapped to chromosome 13q11-q12. This protein was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic hedgehog (Shh) signaling.
Sequence Similarities: Belongs to the heparin-binding growth factors family.
-
Molekulargewicht
- 23 kDa
-
UniProt
- P31371
Target
-